Cargando…
Targeting Podoplanin for the Treatment of Osteosarcoma
PURPOSE: Osteosarcoma, the most common bone malignancy in children, has a poor prognosis, especially when the tumor metastasizes to the lungs. Therefore, novel therapeutic strategies targeting both proliferation and metastasis of osteosarcoma are required. Podoplanin (PDPN) is expressed by various t...
Autores principales: | Takemoto, Ai, Takagi, Satoshi, Ukaji, Takao, Gyobu, Nobuhiko, Kakino, Mamoru, Takami, Miho, Kobayashi, Asami, Lebel, Marie, Kawaguchi, Tokuichi, Sugawara, Minoru, Tsuji-Takayama, Kazue, Ichihara, Kenji, Funauchi, Yuki, Ae, Keisuke, Matsumoto, Seiichi, Sugiura, Yoshiya, Takeuchi, Kengo, Noda, Tetsuo, Katayama, Ryohei, Fujita, Naoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359727/ https://www.ncbi.nlm.nih.gov/pubmed/35381070 http://dx.doi.org/10.1158/1078-0432.CCR-21-4509 |
Ejemplares similares
-
Novel knock‐in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin–targeting agents
por: Ukaji, Takao, et al.
Publicado: (2021) -
A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis)
por: Ukaji, Takao, et al.
Publicado: (2018) -
Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis
por: Takagi, Satoshi, et al.
Publicado: (2021) -
Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis
por: Sekiguchi, Takaya, et al.
Publicado: (2015) -
Podoplanin: An emerging cancer biomarker and therapeutic target
por: Krishnan, Harini, et al.
Publicado: (2018)